Investigators modeled chronic airway disease by treating primary human airway epithelia with the Th2 cytokine IL-13, examining how this impacted dipeptidyl peptidase 4 protein levels along with Middle East respiratory syndrome coronavirus entry and replication.
[Journal Of Infectious Diseases]